Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R DeBaun

Showing results (1-10 of 327) with videos related to

Pageof 33
Sort By:
American Journal of Medical Genetics|February 22, 2002
Screening for cancer in children with Costello syndromeMichael R DeBaun
American Journal of Hematology|December 24, 2009
Finally, a consensus statement on sickle cell disease manifestations: a critical step in improving the medical care and research agenda for individuals with sickle cell diseaseMichael R DeBaun
Expert Review of Hematology|September 23, 2014
Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a reviewMichael R DeBaun
JAMA|September 10, 2014
The challenge of creating an evidence-based guideline for sickle cell diseaseMichael R DeBaun
Blood|April 14, 2020
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemicMichael R DeBaun
The Journal of Pediatrics|October 18, 2005
Hydroxyurea as secondary prevention for stroke in children with sickle cell anemiaMichael R DeBaun
Hematology. American Society of Hematology. Education Program|December 14, 2011
Secondary prevention of overt strokes in sickle cell disease: therapeutic strategies and efficacyMichael R DeBaun
Nature|November 13, 2014
Perspective: thinking beyond survivalMichael R DeBaun
Transactions of the American Clinical and Climatological Association|October 5, 2022
PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE-PART IIMichael R Debaun
Seminars in Hematology|November 10, 2004
Issues regarding study design for initial clinical trials using decitabineMichael R DeBaun
Pageof 33

Showing results (1-10 of 327) with videos related to

Sort By:
Pageof 33
American Journal of Medical Genetics|February 22, 2002
Screening for cancer in children with Costello syndromeMichael R DeBaun
American Journal of Hematology|December 24, 2009
Finally, a consensus statement on sickle cell disease manifestations: a critical step in improving the medical care and research agenda for individuals with sickle cell diseaseMichael R DeBaun
Expert Review of Hematology|September 23, 2014
Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a reviewMichael R DeBaun
JAMA|September 10, 2014
The challenge of creating an evidence-based guideline for sickle cell diseaseMichael R DeBaun
Blood|April 14, 2020
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemicMichael R DeBaun
The Journal of Pediatrics|October 18, 2005
Hydroxyurea as secondary prevention for stroke in children with sickle cell anemiaMichael R DeBaun
Hematology. American Society of Hematology. Education Program|December 14, 2011
Secondary prevention of overt strokes in sickle cell disease: therapeutic strategies and efficacyMichael R DeBaun
Nature|November 13, 2014
Perspective: thinking beyond survivalMichael R DeBaun
Transactions of the American Clinical and Climatological Association|October 5, 2022
PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE-PART IIMichael R Debaun
Seminars in Hematology|November 10, 2004
Issues regarding study design for initial clinical trials using decitabineMichael R DeBaun
Pageof 33